Invesco
RXST icon

Invesco’s RxSight RXST Stock Holding History

Invesco’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
59,517
+6,613
+13% +$39.9K ﹤0.01% 3456
2026
Q1 		$326K Buy
52,904
+32,790
+163% +$272K ﹤0.01% 3308
2025
Q4 		$210K Buy
20,114
+1,249
+7% +$12.5K ﹤0.01% 3508
2025
Q3 		$170K Sell
18,865
-1,218
-6% -$10.7K ﹤0.01% 3596
2025
Q2 		$261K Buy
20,083
+80
+0.4% +$1.2K ﹤0.01% 3422
2025
Q1 		$505K Sell
20,003
-371,160
-95% -$11M ﹤0.01% 3146
2024
Q4 		$13.4M Sell
391,163
-596,434
-60% -$26.9M ﹤0.01% 1677
2024
Q3 		$48.8M Sell
987,597
-66,586
-6% -$3.41M 0.01% 1043
2024
Q2 		$63.4M Buy
1,054,183
+285,228
+37% +$16.3M 0.01% 918
2024
Q1 		$39.7M Buy
768,955
+525,138
+215% +$25.8M 0.01% 1140
2023
Q4 		$9.83M Buy
243,817
+115,466
+90% +$3.39M ﹤0.01% 1828
2023
Q3 		$3.58M Sell
128,351
-40,372
-24% -$1.2M ﹤0.01% 2376
2023
Q2 		$4.86M Buy
168,723
+35,824
+27% +$797K ﹤0.01% 2259
2023
Q1 		$2.22M Buy
+132,899
New +$1.88M ﹤0.01% 2591

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco's RXST Position: Q2 2026 in Review

Invesco increased its RxSight (RXST) stake by 13% in Q2 2026, buying an estimated $39.9K and bringing the position to 59,517 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #3456.

Invesco first reported a position in RXST in Q1 2023 and has held it in 14 quarters since. The position peaked at $63.4M in Q2 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Invesco held 59,517 shares of RxSight worth $287K as of Q2 2026.
  • Invesco bought 6,613 RxSight shares in Q2 2026, an estimated $39.9K.
  • RxSight made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3456 holding.
  • Invesco first reported a position in RxSight in Q1 2023 and has held it in 14 quarters since.
  • Invesco's RxSight position peaked at $63.4M in Q2 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.